Endoscopic Full-Thickness Resection In Colon
Launched by FUNDACIÓ INSTITUT GERMANS TRIAS I PUJOL · Jan 10, 2019
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
Early detection and endoscopic resection of early neoplastic lesions in colon can prevent the development of colon cancer.
The classic endoscopic mucosal resection technique and the submucosal dissection technique require the creation of a submucosal "cushion" by injecting crystalloid substances or colloids. However, these advanced techniques have technical limitations when facing a lesion that presents poor lifting or non-lifting at all as it might be observed in scarring or fibrotic lesions
Endoscopic full-thickness resection (EFTR) in the colon using an over-the-scope clip (OTSC) is a ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (≥18 years) of both sexes.
- • Colonic lesions less than 30mm unresectable en-bloc by other less invasive endoscopic techniques, including lesions suggestive of T1, subepithelial tumors, lesions with diverticular involvement, lesions with no-lifting signs (recurrent, incomplete prior resection or untreated).
- • Patients who give their written informed consent for the procedure and for the study.
- Exclusion Criteria:
- • Refusal to grant informed consent.
- • Neoplastic lesions of the colon with evidence of advanced stage (for example, lymph node involvement) or more than 3 cm in greatest diameter.
- • Any medical, psychological, geographical, or social problem that is significant and uncontrolled that may interfere with the patient's participation in the study or that does not allow adequate follow-up and adherence to the protocol and evaluation of the results of the study.
About Fundació Institut Germans Trias I Pujol
Fundació Institut Germans Trias i Pujol is a leading biomedical research institution based in Spain, dedicated to advancing health sciences through innovative clinical trials and translational research. With a strong commitment to improving patient outcomes, the foundation collaborates with academic, clinical, and industry partners to facilitate cutting-edge studies in various medical fields. Their multidisciplinary approach leverages state-of-the-art facilities and expertise to foster discoveries that translate into practical applications for healthcare, ultimately enhancing the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Madrid, , Spain
Madrid, , Spain
Barcelona, , Spain
Madrid, , Spain
Elche, Alicante, Spain
Pamplona, Navarra, Spain
Ciudad Real, , Spain
Terrassa, Barcelona, Spain
Oviedo, , Spain
Sant Joan Despí, Barcelona, Spain
Madrid, , Spain
Santiago De Compostela, La Coruña, Spain
Manresa, Barcelona, Spain
Castelló De La Plana, Castellón, Spain
Málaga, , Spain
Patients applied
Trial Officials
Hugo I. Uchima Koecklin, MD
Principal Investigator
Medical researcher
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials